Compare BioNano Genomics Inc (BNGO) vs Stitch Fix Inc (SFIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs Stitch Fix Inc — how do they compare? BioNano Genomics Inc trades at $1.19 (market cap $13.66M), while Stitch Fix Inc trades at $3.56 (market cap $497.68M). The key difference: Stitch Fix Inc is far larger — about 36.4× BioNano Genomics Inc's market cap, and Stitch Fix Inc is trading nearer its 52-week high, BioNano Genomics Inc nearer its low. Which is the better fit depends on your goals.
| BNGO | SFIX | |
|---|---|---|
Market Cap | $13.66M | $497.68M |
Sector | Health | Consumer Cyclical |
52-Week High | $4.92 | $5.83 |
52-Week Low | $1.06 | $3.06 |
Enterprise Value | $16.26M | $385.40M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BNGO trades at $1.19, up 2.59% today, with bullish technical signals from moving averages. The company shows improving financials with revenue stabilizing around $29M annually and narrowing losses, though it remains unprofitable. Recent earnings have consistently beaten expectations, and analyst sentiment is positive with 57% buy ratings. Key developments include debt retirement and scientific publications highlighting optical genome mapping adoption.
The outlook is cautiously optimistic given improving fundamentals and positive analyst coverage, but significant risks remain due to persistent losses and negative cash flow. Investment opportunity lies in the company's technology adoption growth, while primary risks include profitability challenges and competitive pressures in the genomics space.
Stitch Fix (SFIX) trades at $3.565, down 10.2% in the past day, reflecting recent volatility. The stock shows a bullish technical signal with improving earnings trends, as recent quarters beat EPS estimates. Revenue stabilized at $1.27B in 2025, with net losses narrowing to -$28.74M, indicating progress toward profitability. News highlights AI-driven personalization efforts and new executive appointments aimed at growth.
The outlook suggests a turnaround opportunity, supported by a low P/S ratio of 0.37 and a consensus price target of $4.75 (33% upside). Risks include persistent net losses, competitive pressures, and consumer spending sensitivity. Analysts are mixed, with 27% buy ratings, but improving cash flow and debt-free balance sheet provide stability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About Stitch Fix Inc
Stitch Fix Inc offers personal style service for men and women. The company engages in delivering one-to-one personalization to clients through the combination of data science and human judgment. It provides a shipment service called A FIX where the stylist's hand selects items from several merchandises with analysis of client and merchandise data to provide a personalized shipment of apparel, shoes, and accessories suited to the client's needs. The company offers products across categories, brands, product types and price points including Women's, Petite, Maternity, Men's and Plus. It also offers various product types, including denim, dresses, blouses, skirts, shoes, jewelry and handbags, and sells merchandise across various range of price points.
Read more on SFIX →
